Skip to content
Recall Observatory FDA recall evidence

Drug product

Semaglutide Injection, 8mg/3.2mL (2.5 mg/mL), 3.2mL Multidose Vial, For Subcutaneous Use, Rx Only, Mfd by: ProRx, 619 Jeffers Cir, Exton, PA 19341. NDC: 84139-225-09

D-0117-2026

October 15, 2025

Class II

Product summary

Firm
ProRx LLC
Event
Event 97808
Status
Ongoing
Classification
Class II
Quantity
11,119 vials
Official record key
drug-enforcement:D-0117-2026

Official wording

Reason: Lack of Assurance of Sterility

Code information: Lot Prorx051525-1, Prorx051525-2, Prorx051525-3 and Prorx051525-4

Distribution pattern: TX and UT

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility